This company listing is no longer active
Spectrum Pharmaceuticals Dirección
Dirección controles de criterios 1/4
Spectrum Pharmaceuticals' CEO is Tom Riga, appointed in Dec 2021, he has a tenure of 1.67 years. His total yearly compensation is $2.60M , comprised of 25% salary and 75% bonuses, including company stock and options. He directly owns 0.26% of the company’s shares, worth €489.48K. The average tenure of the management team and the board of directors is 1.5 years and 2.5 years respectively.
Información clave
Tom Riga
Chief Executive Officer (CEO)
US$2.6m
Compensación total
Porcentaje del salario del CEO | 25.0% |
Permanencia del CEO | 1.7yrs |
Participación del CEO | 0.3% |
Permanencia media de la dirección | 1.5yrs |
Promedio de permanencia en la Junta Directiva | 2.5yrs |
Actualizaciones recientes de la dirección
Recent updates
Análisis de compensación del CEO
Fecha | Compensación total | Salario | Ingresos de la empresa |
---|---|---|---|
Mar 31 2023 | n/a | n/a | -US$68m |
Dec 31 2022 | US$3m | US$650k | -US$78m |
Sep 30 2022 | n/a | n/a | -US$106m |
Jun 30 2022 | n/a | n/a | -US$117m |
Mar 31 2022 | n/a | n/a | -US$138m |
Dec 31 2021 | US$4m | US$550k | -US$158m |
Sep 30 2021 | n/a | n/a | -US$169m |
Jun 30 2021 | n/a | n/a | -US$184m |
Mar 31 2021 | n/a | n/a | -US$166m |
Dec 31 2020 | US$3m | US$550k | -US$171m |
Sep 30 2020 | n/a | n/a | -US$162m |
Jun 30 2020 | n/a | n/a | -US$140m |
Mar 31 2020 | n/a | n/a | -US$136m |
Dec 31 2019 | US$4m | US$550k | -US$135m |
Sep 30 2019 | n/a | n/a | -US$148m |
Jun 30 2019 | n/a | n/a | -US$191m |
Mar 31 2019 | n/a | n/a | -US$147m |
Dec 31 2018 | US$5m | US$500k | -US$127m |
Sep 30 2018 | n/a | n/a | -US$102m |
Jun 30 2018 | n/a | n/a | -US$51m |
Mar 31 2018 | n/a | n/a | -US$87m |
Dec 31 2017 | US$1m | US$420k | -US$101m |
Compensación vs. Mercado: Tom's total compensation ($USD2.60M) is above average for companies of similar size in the German market ($USD684.36K).
Compensación vs. Ingresos: Tom's compensation has been consistent with company performance over the past year.
CEO
Tom Riga (48 yo)
1.7yrs
Permanencia
US$2,595,633
Compensación
Mr. Thomas J. Riga, also known as Tom, is President, Chief Executive Officer and Director at Spectrum Pharmaceuticals, Inc. since December 30, 2021. He had been the Chief Operating Officer at Spectrum Phar...
Equipo directivo
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
President | 1.7yrs | US$2.60m | 0.26% $ 489.5k | |
Executive VP & CFO | 1.3yrs | US$46.25k | 0.051% $ 98.3k | |
Executive VP | 5.5yrs | US$1.50m | 0.11% $ 217.8k | |
Executive VP & Chief Business Officer | less than a year | sin datos | sin datos |
1.5yrs
Permanencia media
48yo
Promedio de edad
Equipo directivo experimentado: NTR's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Miembros de la Junta
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
President | 1.7yrs | US$2.60m | 0.26% $ 489.5k | |
Independent Director | 3.3yrs | US$178.83k | 0.0020% $ 3.8k | |
Independent Chairman of the Board | 5.5yrs | US$202.58k | 0.021% $ 40.0k | |
Independent Director | 4.8yrs | US$181.33k | 0.13% $ 253.4k | |
Independent Director | 1.3yrs | US$158.53k | sin datos | |
Director | 1.4yrs | US$183.93k | 0.0023% $ 4.5k |
2.5yrs
Permanencia media
53.5yo
Promedio de edad
Junta con experiencia: NTR's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.